Bharat Biotechs Covaxin Approved For Emergency Use By WHO
Please Subscribe and Get Daily Updates in Your Inbox!!!
Highlights:
♦ This is a significant step forward in India’s fight against Covid-19.
♦ Covaxin is a vaccine developed by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
♦ It is totally “made in India.” Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson – Janssen, Moderna, and Sinopharm have all had their Covid-19 vaccines authorized by the WHO for emergency use.
♦ Last month, the technical advisory panel requested additional clarity from Bharat Biotech for its final risk assessment, which caused the emergency listing to be postponed.
♦ Covaxin has been recommended for emergency use listing by the technical advisory group, which met to make the final decision.
♦ Covaxin has been shown to be effective against symptomatic COVID-19 at 77.8% and 65.2 percent against the novel Delta variant at 65.2 percent.
